首页> 外文OA文献 >PGI5 COMPARISON OF HEALTH CARE UTILIZATIONS BETWEEN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WHO SWITCHED FROM A BRANDED PROTON PUMP INHIBITOR TO A GENERIC PROTON PUMP INHIBITOR AND VICE VERSA

【2h】

PGI5 COMPARISON OF HEALTH CARE UTILIZATIONS BETWEEN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WHO SWITCHED FROM A BRANDED PROTON PUMP INHIBITOR TO A GENERIC PROTON PUMP INHIBITOR AND VICE VERSA

机译：PGI5比较胃食管反流病患者从品牌的质子泵抑制剂转换为一般的质子泵抑制剂以及副产品时的卫生保健利用情况

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xie L.; Baser E.; Wang L.; Baser O.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The impact of proton pump inhibitor compliance on health-care resource utilization and costs in patients with gastroesophageal reflux disease. [J] . Gosselin A, Luo R, Lohoues H, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2009,第1期

机译：质子泵抑制剂依从性对胃食管反流病患者医疗资源利用和成本的影响。
2. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life [J] . Fuminao Takeshima, Keiichi Hashiguchi, Yasunori Onitsuka, Medical science monitor : . 2015,第1期

机译：质子泵抑制剂难治性胃食管反流病患者的临床特征以及改用20 mg艾美拉唑对反流症状和生活质量的影响
3. Characteristics of refractory gastroesophageal reflux disease (GERD) symptoms -is switching proton pump inhibitors based on the patient's CYP2C19 genotype an effective management strategy? [J] . Toshihisa Takeuchi, Kazuhiro Oota, Satoshi Harada, Internal medicine. . 2015,第2期

机译：难治性胃食管反流病（GERD）症状的特征-根据患者的CYP2C19基因型切换质子泵抑制剂是否是有效的治疗策略？
4. Proton Pump Inhibitors as a Biological Strategy to Control Cell-Mediated Resorption ofCalcium Phosphate Biomaterials [C] . Kathy Rzeszutek, Feryal Sarraf, John E. Davies Annual meeting of the Society For Biomaterials . 2002

机译：质子泵抑制剂作为一种生物策略来控制细胞介导的磷酸钙生物材料的吸收
5. Characterization of Esophageal Hypervigilance in a Cohort of Gastroesophageal Reflux Disease Proton-Pump Inhibitor Non-Responders [D] . Guadagnoli, Livia Anna. 2020

机译：食糖回流型疾病群体泵抑制剂非响应者食管血管性诱导的表征
6. Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life [O] . Fuminao Takeshima, Keiichi Hashiguchi, Yasunori Onitsuka, 2015

机译：质子泵抑制剂难治性胃食管反流病患者的临床特征以及改用20 mg艾美拉唑对反流症状和生活质量的影响
7. The Impact of Proton Pump Inhibitor Compliance on Health-Care Resource Utilization and Costs in Patients with Gastroesophageal Reflux Disease [O] . Gosselin Antoine, Luo Roger, Lohoues Herve, 2009

机译：质子泵抑制剂依从性对胃食管反流病患者保健资源利用和成本的影响

PGI5 COMPARISON OF HEALTH CARE UTILIZATIONS BETWEEN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE WHO SWITCHED FROM A BRANDED PROTON PUMP INHIBITOR TO A GENERIC PROTON PUMP INHIBITOR AND VICE VERSA

著录项

引文网络

相似文献

相关主题

期刊订阅